Bhat Akshatha K, Krishna Kumar Venugopalan
Department of Shalakya Tantra, Yenepoya Ayurveda Medical College and Hospital, Naringana, Mangalore, Karnataka, 575018, India.
Department of Netra, National Ayurveda Research Institute for Panchakarma, CCRAS, Cheruthuruthy, Thrissur, 679531, India.
J Ayurveda Integr Med. 2024 Nov-Dec;15(6):100994. doi: 10.1016/j.jaim.2024.100994. Epub 2024 Nov 27.
This case is about an Episodic Cluster Headache (ECH) for 13 years treated effectively by Jaloukavacharana, Nasya and Ayurveda oral medications. It commenced with sudden episodic headache once or twice a day for a period of 40 days in a row, every year in the month of January and February. The pain intensity was 10/10 in numeric pain intensity scale, HIT -6 (Headache Impact Test) Score- 69, CHIQ (Cluster headache impact questionnaire) Score- 34 DASS 21 Scale- Depression- 8 anxiety-5 stress-11. Ayurveda treatment included one sitting of Jaloukavacharana and seven days of Kumkumadighrita Nasya. Drakshadi Kashaya, Soothashekararasa and Avipatthikara choorna were given internally. Patient reported no attacks of ECH thereafter with the HIT 6 score -36, CHIQ Score-0 and DASS-21 (Depression - 0, Anxiety-0, Stress- 0) after treatment. This line of treatment prevented the recurrence of ECH attacks with overall improvement in the quality of life without any known side effects.
该病例为一名患有发作性丛集性头痛(ECH)13年的患者,通过 Jaloukavacharana、滴鼻疗法和阿育吠陀口服药物得到有效治疗。该病始于每年1月和2月,连续40天每天突然发作一到两次头痛。疼痛强度在数字疼痛强度量表上为10/10,头痛影响测试(HIT -6)评分为69,丛集性头痛影响问卷(CHIQ)评分为34,抑郁、焦虑和压力量表(DASS 21)评分中,抑郁为8,焦虑为5,压力为11。阿育吠陀治疗包括一次 Jaloukavacharana治疗和七天的金盏花滴鼻疗法。内服德拉克沙迪煎剂、舒塔舍卡拉拉萨和阿维帕蒂卡拉散。患者报告此后未再发作ECH,治疗后HIT 6评分为36,CHIQ评分为0,DASS -21(抑郁-0,焦虑-0,压力-0)。这种治疗方法预防了ECH发作的复发,全面改善了生活质量,且无任何已知副作用。